Cover Story
Clinical
HRD results can vary widely, depending on what assay you choose—even as they guide treatment choices
Homologous recombination deficiency tests are used routinely in the clinic to determine which patients get PARP inhibitors.
In Brief
Funding Opportunities
Clinical Roundup
